X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
oncology (32) 32
index medicus (28) 28
male (27) 27
female (25) 25
lung neoplasms - pathology (21) 21
middle aged (21) 21
aged (20) 20
cancer (18) 18
chemotherapy (16) 16
lung neoplasms - genetics (15) 15
treatment outcome (15) 15
adult (13) 13
lung neoplasms - drug therapy (13) 13
respiratory system (13) 13
prognosis (12) 12
aged, 80 and over (10) 10
carcinoma, non-small-cell lung - genetics (10) 10
carcinoma, non-small-cell lung - pathology (10) 10
gene amplification (10) 10
neoplasm staging (9) 9
non-small cell lung cancer (9) 9
pulmonary/respiratory (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoma (8) 8
small cell lung cancer (8) 8
tumors (8) 8
adenocarcinoma - genetics (7) 7
adenocarcinoma - pathology (7) 7
cell lung-cancer (7) 7
mutation (7) 7
adenocarcinoma (6) 6
antineoplastic agents - therapeutic use (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
egfr (6) 6
erlotinib (6) 6
immunohistochemistry (6) 6
immunotherapy (6) 6
ipilimumab (6) 6
lung cancer, non-small cell (6) 6
pathology (6) 6
small cell lung carcinoma - pathology (6) 6
biomarkers, tumor - genetics (5) 5
biomarkers, tumor - metabolism (5) 5
care and treatment (5) 5
fish (5) 5
follow-up studies (5) 5
gefitinib (5) 5
hematology, oncology and palliative medicine (5) 5
immunology (5) 5
in situ hybridization, fluorescence (5) 5
lung cancer (5) 5
lung neoplasms - mortality (5) 5
lung neoplasms - surgery (5) 5
met (5) 5
nsclc (5) 5
receptor protein-tyrosine kinases - genetics (5) 5
receptor, epidermal growth factor - genetics (5) 5
research (5) 5
adenocarcinoma - drug therapy (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
breast neoplasms - genetics (4) 4
chemotherapy, adjuvant (4) 4
crizotinib (4) 4
expression (4) 4
gene expression (4) 4
in-situ hybridization (4) 4
medicine & public health (4) 4
metastasis (4) 4
neoplasms - drug therapy (4) 4
open-label (4) 4
pulmonary and respiratory medicine (4) 4
small cell lung carcinoma - drug therapy (4) 4
survival (4) 4
survival rate (4) 4
translocation, genetic (4) 4
1st-line treatment (3) 3
adenocarcinoma - surgery (3) 3
amplification (3) 3
analysis (3) 3
animals (3) 3
antibodies (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
breast cancer (3) 3
c-met (3) 3
carcinoma, large cell - pathology (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
carcinoma, non-small-cell lung - surgery (3) 3
carcinoma, squamous cell - genetics (3) 3
carcinoma, squamous cell - pathology (3) 3
cell line, tumor (3) 3
chemoresistance (3) 3
chromosome aberrations (3) 3
cisplatin - administration & dosage (3) 3
clinical trials as topic (3) 3
combination (3) 3
combined modality therapy (3) 3
epidermal growth factor receptor (3) 3
fluorescence (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Archivos de Bronconeumología (English Edition), ISSN 1579-2129, 03/2019, Volume 55, Issue 3, pp. 124 - 125
Journal Article
Immunotherapy, ISSN 1750-743X, 01/2016, Volume 8, Issue 5, pp. 511 - 511
One of the strategies to enhance immune response against tumors has been the use of vaccines against tumor-associated antigens (TAAs). MUC1 is a TAA that is... 
Journal Article
Archivos de Bronconeumología, ISSN 0300-2896, 2018, Volume 55, Issue 3, pp. 124 - 125
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, p. e107200
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 12/2007, Volume 106, Issue 2, pp. 181 - 189
Journal Article
Journal Article
Archivos de Bronconeumología, ISSN 0300-2896, 2018, Volume 55, Issue 5, pp. 268 - 269
Journal Article
Archivos de Bronconeumología (English Edition), ISSN 1579-2129, 05/2019, Volume 55, Issue 5, pp. 268 - 269
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. LB-143 - LB-143
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 9045 - 9045
Journal Article
Future Oncology, ISSN 1479-6694, 01/2015, Volume 11, Issue 2, pp. 267 - 277
Afatinib is an irreversible ErbB family blocker tyrosine kinase inhibitor (TKI), which has recently been approved for the treatment of patients with EGFR M+... 
afatinib | mutation | L858R | adverse events | non-small lung cancer | Del19 | EGFR | 1ST-LINE TREATMENT | GEFITINIB | ADENOCARCINOMA | OPEN-LABEL | CHEMOTHERAPY | CELL LUNG-CANCER | PHASE-II TRIAL | ONCOLOGY | QUALITY-OF-LIFE | INHIBITORS | ERLOTINIB
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.